Kwan-Sun Lee

Title: The Innovative Contributions of Kwan-Sun Lee

Introduction

Kwan-Sun Lee is a notable inventor based in Seoul, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the preparation of important compounds. His work exemplifies the intersection of chemistry and innovation, showcasing how scientific advancements can lead to practical applications in medicine.

Latest Patents

Kwan-Sun Lee holds a patent for a method of preparing amlodipine. This method involves subjecting a pyrrole derivative, methyl aminocrotonate, and 2-chlorobenzaldehyde to a Hantzsch reaction. The process results in a high yield of amlodipine by converting the pyrrole residue of the resulting 1,4-dihydropyridine derivative to an amine group through the action of hydroxylamine hydrochloride. This innovative approach enhances the efficiency of amlodipine production, which is crucial for its use in treating hypertension.

Career Highlights

Kwan-Sun Lee is currently employed at Hanmi Pharmaceutical Co., Ltd., a leading company in the pharmaceutical industry. His role at Hanmi Pharm allows him to apply his expertise in drug development and contribute to the advancement of healthcare solutions. His dedication to research and innovation has positioned him as a valuable asset in the field.

Collaborations

Kwan-Sun Lee has collaborated with notable colleagues, including Kyung-Ik Lee and Young-Ho Moon. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and enhances the quality of research and development within the company.

Conclusion

Kwan-Sun Lee's contributions to the field of pharmaceuticals through his innovative patent for amlodipine preparation highlight the importance of scientific research in developing effective medical treatments. His work continues to impact the industry positively, demonstrating the vital role of inventors in advancing healthcare.